Study identifier:Alves Artist 07/10
ClinicalTrials.gov identifier:NCT00608218
EudraCT identifier:N/A
CTIS identifier:N/A
Ciclesonide for the Therapy of Asthma During the Cold Season.
asthma
-
No
Ciclesonide
All
2100
Observational
12 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Sept 2016 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|---|
Artist | Drug: Ciclesonide This is an observational study. Therefore, the physician decides about dosage according to individual needs. |